# Deerfield: portfolio, investments and team > Deerfield is a vc firm based in United States. 198 investments on record, 17 in the last 12 months, latest Oct 2026. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/deerfield (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Deerfield Last cheque observed Oct 2026; 198 cheques on record. Email Deploying now New fund $573M, Nov 2023 VC firm Seed Series A Healthcare Follow Deerfield and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fdeerfield) Deploying now **63%** of best year **17** **cheques in 12 months**, 198 on record Since the last cheque **1** days **00** hrs **00** min **00** sec Median round **$50M** Rounds led **3 of 198** Sole investor **55 rounds** Exits **5 from the portfolio** Mostly in **United States, 82%** Pitch Deerfield ## Deerfield highlights - 01 17 cheques in the last 12 months - 02 Mostly Venture and Series A: 51% of its rounds - 03 Sole investor in 55 rounds, median $50M - 04 5 exits from the portfolio ## What they do > We work across the healthcare ecosystem to build companies independently and with strategic partners. From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A - **Sectors:** Healthcare - **Based in:** New York, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **198 appearances** - **2026** 13 rounds - **Oct** **[Setara Biosciences](https://millionrounds.com/company/setara-biosciences)** Series A · US · Pulse 2.0 **$90M** With 6 others - **Sept** **[MMI](https://millionrounds.com/company/mmi)** Venture **$20M** With 4 others - **Aug** **[Petfolk](https://millionrounds.com/company/petfolk)** Venture · US **$40M** With 1 other - **May** **[Abivax](https://millionrounds.com/company/abivax)** FR **$45M** With 4 others - **Apr** **[Ray Therapeutics](https://millionrounds.com/company/ray-therapeutics)** Series B · US · 4BIO Capital **$125M** With 10 others - **Apr** **[Neomorph](https://millionrounds.com/company/neomorph)** Series B · US · TechStartups **$100M** *Led* - **Apr** **[AdaptHealth](https://millionrounds.com/company/adapthealth)** Debt · US **$1.1B** Sole investor - **Apr** **[GH Research](https://millionrounds.com/company/gh-research)** IE **$118M** With 4 others - **Apr** **[Adela](https://millionrounds.com/company/adela)** US **$5.0M** With 2 others - **Apr** **[TriNetX](https://millionrounds.com/company/trinetx)** Venture · US **$200M** With 1 other - **Mar** **[Atlas Data Storage](https://millionrounds.com/company/atlas-data-storage)** Venture · US **Undisclosed** With 2 others - **Feb** **[Bicara Therapeutics](https://millionrounds.com/company/bicara-therapeutics)** US **$150M** With 3 others - **Jan** **[Foghorn Therapeutics](https://millionrounds.com/company/foghorn-therapeutics)** US **$50M** With 3 others - **2025** 23 rounds - **Dec** **[Excelsior Sciences](https://millionrounds.com/company/excelsior-sciences)** Series A · US · AlleyWatch **$70M** *Led* - **Dec** **BIOMx** **$3.0M** With 3 others - **Dec** **[Relation Therapeutics](https://millionrounds.com/company/relation-therapeutics)** Venture · GB **$26M** With 5 others - **Nov** **[Nuvalent](https://millionrounds.com/company/nuvalent)** Secondary · US **$500M** With 4 others - **Oct** **[Valneva](https://millionrounds.com/company/valneva)** Debt · FR **$215M** With 3 others - **Oct** **[Octave](https://millionrounds.com/company/octave)** Venture · US **Undisclosed** With 3 others - **Oct** **[ADC Therapeutics](https://millionrounds.com/company/adc-therapeutics)** CH **$60M** With 3 others - **Sept** **[Axon Therapies](https://millionrounds.com/company/axon-therapies)** Series A · US **$32M** With 1 other - **Sept** **[ARS Pharmaceuticals](https://millionrounds.com/company/ars-pharmaceuticals)** Debt · US **$100M** With 2 others - **Aug** **[Reprieve Cardiovascular](https://millionrounds.com/company/reprieve-cardiovascular)** Series B · US **$61M** Sole investor - **Jun** **[myLaurel](https://millionrounds.com/company/mylaurel)** Seed · US · AlleyWatch **$12M** With 7 others - **Jun** **[Actio Biosciences](https://millionrounds.com/company/actio-biosciences)** Series B · US **$66M** With 1 other - **May** **[NeuroFlow](https://millionrounds.com/company/neuroflow)** Grant · US **$2.8M** With 3 others - **May** **[Cohere Health](https://millionrounds.com/company/cohere-health)** Series C · US **$90M** With 4 others - **May** **[Advantia Health](https://millionrounds.com/company/advantia-health)** Venture · US **$5.0M** Sole investor - **Apr** **[Ascertain](https://millionrounds.com/company/ascertain)** Series A · US **$10M** Sole investor - **Apr** **[Ray Therapeutics](https://millionrounds.com/company/ray-therapeutics)** Grant · US **$8.0M** With 2 others - **Mar** **[Octave](https://millionrounds.com/company/octave)** Series C · US **$32M** With 2 others - **Mar** **[Lomond Therapeutics](https://millionrounds.com/company/lomond-therapeutics)** Venture · US **$20M** With 1 other - **Feb** **[GH Research](https://millionrounds.com/company/gh-research)** IE **$150M** With 4 others - **Feb** **[Perceive Pharma](https://millionrounds.com/company/perceive-pharma)** Series A · US **$15M** With 2 others - **Jan** **[Liquid Wire](https://millionrounds.com/company/liquid-wire)** Debt · US **$2.6M** Sole investor - **Jan** **[LetsGetChecked](https://millionrounds.com/company/letsgetchecked)** Series F · US **$165M** With 3 others - **2024** 20 rounds - **Dec** **[Pleno](https://millionrounds.com/company/pleno)** Series B · US **$25M** With 2 others - **Nov** **[BlinkRx](https://millionrounds.com/company/blinkrx)** Series D · US **$140M** With 3 others - **Nov** **[Intus Care](https://millionrounds.com/company/intus-care)** Venture · US **$12M** With 5 others - **Nov** **[Cortica](https://millionrounds.com/company/cortica)** Venture · IL **$80M** With 5 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **9 named** AC **Alexis Cazé** Chief Operating Officer i Form ADV BS **Bryan Scott Sendrowski** Chief Financial Officer i Form ADV DJ **David Justus Clark** General Counsel i Form ADV GE **Graham E. Cook** Director i Filing they signed JE **James Edward Flynn** President of J.E. Flynn Capital, LLC, the General Partner of Deerfield Capital, L.P., the General Partner i Filing they signed JD **Jonathan David Isler** Chief Financial Officer, Funds i Form ADV NL **Nicholas Lane** Director i Filing they signed PE **Peter E. Young** Director i Filing they signed RT **Robert Todd Snetiker** Chief Compliance Officer i Form ADV We also hold **97** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$19B** assets it manages Oct 2026 **21+** funds on file numbered funds in its name **Registered** investment adviser full reporting to the SEC - **Legal name:** Deerfield Management Company, L.P. - **SEC number:** CRD 157876 Funds on its Form ADV **11** private funds, **$16B** in gross assets · filed Mar 2024 Hedge **10** Private equity **1** - Deerfield Partners, L.P. *Hedge* 171 investors $6.2B - Deerfield Private Design Fund IV, L.P. *Hedge* 203 investors $3.7B - Deerfield Private Design Fund III, L.P. *Hedge* 152 investors $1.8B - Deerfield Healthcare Innovations Fund, L.P. *Hedge* 124 investors $1.5B - Deerfield Private Design Fund V, L.P. *Hedge* 95 investors $1.5B - Deerfield Healthcare Innovations Fund II, L.P. *Hedge* 96 investors $882M - Deerfield Healthcare Innovations Fund III, L.P. *Hedge* 36 investors $334M - Deerfield Private Design Fund II, L.P. *Hedge* 62 investors $118M - Deerfield Private Design International II, L.P. *Hedge* 42 investors $113M - Deerfield PDI Financing II, L.P. *Private equity* 42 investors $22M And 1 more on the filing. ## Exits from the portfolio Companies it backed that were later bought or listed **5 in all** **[Auspex Pharmaceuticals](https://millionrounds.com/company/auspex-pharmaceuticals)** Bought by [Teva Pharmaceutical Industries](https://millionrounds.com/fund/teva-pharmaceutical-industries) **$3.2B** Mar 2015 **[Foundation Medicine](https://millionrounds.com/company/foundation-medicine)** Bought by Roche **Undisclosed** Jan 2015 **[Foundation Medicine](https://millionrounds.com/company/foundation-medicine)** Listed **$108M** Jul 2013 **[Tengion](https://millionrounds.com/company/tengion)** Listed **Undisclosed** Apr 2010 **[Third Wave Technologies](https://millionrounds.com/company/third-wave-technologies)** Bought by Hologic **$567M** Jun 2008 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$573M** raised in Nov 2023 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Median round joined **$50M** the round, not its cheque Alone, median **$50M** Led 3 of 198 rounds **2%** - **Sole investor:** 55 rounds - **Last cheque:** Oct 2026 - **Exits:** 5 from the portfolio Rounds by stage said on their site - Venture *39* - Series A said *29* - Series B *27* - Series C *22* - Debt *17* - Seed said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 21 - [OrbiMed](https://millionrounds.com/fund/orbimed) 15 - [Venrock](https://millionrounds.com/fund/venrock) 12 - [Casdin Capital](https://millionrounds.com/fund/casdin-capital) 11 - [Wellington Management](https://millionrounds.com/fund/wellington-management) 11 - [Redmile Group](https://millionrounds.com/fund/redmile-group) 10 **Pitching Deerfield?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Deerfield. A count of rooms they were both in, not a relationship either has claimed. [**RA Capital Management** Private equity **21** rounds together](https://millionrounds.com/fund/ra-capital-management)[**OrbiMed** Private equity **15** rounds together](https://millionrounds.com/fund/orbimed)[**Venrock** VC firm **12** rounds together](https://millionrounds.com/fund/venrock)[**Casdin Capital** VC firm **11** rounds together](https://millionrounds.com/fund/casdin-capital)[**Wellington Management** VC firm **11** rounds together](https://millionrounds.com/fund/wellington-management)[**Redmile Group** VC firm **10** rounds together](https://millionrounds.com/fund/redmile-group)[**Fidelity** VC firm **8** rounds together](https://millionrounds.com/fund/fidelity)[**Google Ventures** Corporate VC **8** rounds together](https://millionrounds.com/fund/gv)[**LD Capital** VC firm **8** rounds together](https://millionrounds.com/fund/xie)[**Cormorant Asset Management** Private equity **7** rounds together](https://millionrounds.com/fund/cormorant-asset-management)[**Adage Capital Management** Asset manager **6** rounds together](https://millionrounds.com/fund/adage-capital-management)[**Foresite Capital** Private equity **6** rounds together](https://millionrounds.com/fund/forsite-capital) ## Recently backed The latest companies Deerfield put money into. [**Petfolk** $40M · Aug 2026](https://millionrounds.com/company/petfolk)[**Abivax** $45M · May 2026](https://millionrounds.com/company/abivax)[**GH Research** $118M · Apr 2026](https://millionrounds.com/company/gh-research)[**Adela** $5.0M · Apr 2026](https://millionrounds.com/company/adela)[**TriNetX** $200M · Apr 2026](https://millionrounds.com/company/trinetx)[**Atlas Data Storage** Mar 2026](https://millionrounds.com/company/atlas-data-storage) ## Mentioned on podcasts Episodes that name Deerfield in their description, not their title. - [Invest Like the Best](https://millionrounds.com/podcasts/invest-like-the-best) 21 Apr 2026 · 1h 32m Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468] Mentions [Revolution](https://millionrounds.com/fund/revolution)[Deerfield](https://millionrounds.com/fund/deerfield) Apple PodcastsShow page ## Quick answers about Deerfield ### What does Deerfield invest in? Deerfield invests most often at Venture and Series A (51% of the rounds on record), in sectors such as Healthcare. ### How active is Deerfield? 198 investments on record, 17 of them in the last 12 months, and it led 3. The most recent was in Oct 2026. ### What has Deerfield invested in recently? Its most recent investments on record: Setara Biosciences (Series A, Oct 2026), MMI (Venture, Sept 2026) and Petfolk (Venture, Aug 2026). ### How big are Deerfield's cheques? The median round it joins is $50M. ### Does Deerfield lead rounds? Sometimes: it led 3 of its 198 investments on record (2%). ### Where does Deerfield invest? Most of the companies it backs are in the United States (82%), France (5%) and Ireland (5%). ### Is Deerfield investing now? Yes: it is actively investing, with 17 investments in the last 12 months. ### Who does Deerfield invest alongside? Most often RA Capital Management (21 rounds together), OrbiMed (15 rounds together) and Venrock (12 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=deerfield) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=deerfield)